Search results
Results from the WOW.Com Content Network
Antibiotics are the first line treatment for pneumonia; however, they are neither effective nor indicated for parasitic or viral infections. Acute bronchitis typically resolves on its own with time. [citation needed] In 2015 there were about 291 million cases. [1] These resulted in 2.74 million deaths down from 3.4 million deaths in 1990.
Cefdinir, sold under the brand name Omnicef among others, is an antibiotic used to treat pneumonia, otitis media, strep throat, and cellulitis. [1] It is a less preferred option for pneumonia, otitis media, and strep throat which may be used in those with a severe penicillin allergy. [1] It is taken by mouth. [1]
Daiichi, working with Johnson & Johnson as it had with ofloxacin, obtained FDA approval in 1996 under the brand name Levaquin [65] to treat bacterial sinusitus, bacterial exacerbations of bronchitis, community-acquired pneumonia, uncomplicated skin infections, complicated urinary tract infections, and acute pyelonephritis. [3]
A lower respiratory tract infections like bronchitis or pneumonia. ... Take antibiotics for a bacterial infection, as recommended by your doctor ... The best laundry detergent sheets of 2025. AOL.
[1] [11] Antibiotics should generally not be used. [12] An exception is when acute bronchitis is due to pertussis. [1] Tentative evidence supports honey and pelargonium to help with symptoms. [1] Acute bronchitis is one of the most common diseases. [3] [13] About 5% of adults are affected and about 6% of children have at least one episode a year.
The percentage of children ages 2-4 diagnosed with a respiratory illness-bacteria grew from 1% to 7.2% between March 31 and Oct. 5, the CDC reported.
Other than this and one other clinical trial into its efficacy as a treatment for pneumocystis pneumonia, [60] data on its use in both the treatment and prevention of pneumocystis pneumonia is significantly lacking. Toxoplasmosis: Yes: Prevention only: Yes: Clinical trials have confirmed its prophylactic and therapeutic utility in cases of ...
Gemifloxacin mesylate, sold under the brand name Factive among others, is a broad-spectrum quinolone antibacterial agent used in the treatment of acute bacterial exacerbation of chronic bronchitis and mild-to-moderate pneumonia. It is taken by mouth. Vansen Pharma Inc. licensed the active ingredient from LG Life Sciences of Korea. [citation needed]